Compare GRC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRC | TNDM |
|---|---|---|
| Founded | 1933 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1994 | 2013 |
| Metric | GRC | TNDM |
|---|---|---|
| Price | $65.98 | $21.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $28.16 |
| AVG Volume (30 Days) | 141.9K | ★ 1.6M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ 32.03 | N/A |
| EPS | ★ 2.02 | N/A |
| Revenue | $682,389,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | $6.62 | $8.11 |
| Revenue Next Year | $4.66 | $11.85 |
| P/E Ratio | $33.91 | ★ N/A |
| Revenue Growth | 3.44 | ★ 7.93 |
| 52 Week Low | $32.38 | $10.00 |
| 52 Week High | $73.24 | $29.65 |
| Indicator | GRC | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 51.20 | 52.06 |
| Support Level | $60.08 | $19.70 |
| Resistance Level | $67.61 | $21.54 |
| Average True Range (ATR) | 2.27 | 1.15 |
| MACD | 0.08 | 0.18 |
| Stochastic Oscillator | 38.08 | 82.73 |
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.